Piper Jaffray
Piper Jaffray is a client-focused, middle market investment bank and institutional securities firm founded in 1895 and based in Minneapolis, Minnesota.
Its Investment Banking activities include raising capital through equity and debt financings for corporate clients; providing financial advisory services relating to mergers and acquisitions to consumer, financial institutions, health care, technology, alternative energy, business services, and industrial growth sectors; underwriting debt issuances for government and non-profit clients; and providing financial advisory and interest rate risk management services.
The company's equity and fixed income institutional sales and trading activities include equity and fixed income advisory and trade execution services for public and private corporations, public entities, non-profit clients, and institutional investors.
-
Sinovac (SVA) Prices 11.5M Shares at $5.75/Share for Net Proceeds of $62M
-
Sinovac Biotech (SVA) Prices 10M Common Offering at $5.75/Share
-
Piper Jaffray Reiterates an 'Overweight' on Sinovac Biotech Ltd. (SVA); Chinese Government Increasing H1N1 Purchases
-
Notable Analyst Rating Changes 11/16: COH, JWN, GNK, ESEA, SVA, YGE Upgraded; PARD, GPS, JCP, DLTR Downgraded
-
Piper Jaffray Upgrades Sinovac Biotech Ltd. (SVA) to Overweight; Raises PT & Estimates
-
Notable Analyst Rating Changes 7/9: GU, WB, RIG, NUE Upgraded; NCC, CCE, DRIV, INTU Downgraded
